QGLY - Funny Name Great Product. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QGLY - Funny Name Great Product.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arris who wrote (8911)	8/7/1999 8:39:00 AM
From: Arris	Read Replies (1) of 8960

Oh yes! Quigley does no research, and does not know how its product works. Sure we all know about the theoretical blockage of the viral attachment site, but how does the stuff get to the nose? Why doesn't the other guy's stuff get there, or does it? They don't hire research people to figure this stuff out. Perhaps, they don't think it is necessary. Osmosis? Give me a break!The rise in blood level from the lozenge can not transfer the appropriate amount to the nose, if you know your pharmacokinetics and dynamics. So we are all wondering how the stuff gets to the nose. Bayer on the other hand did its homework 110 years ago and is still doing it now, on many products. What does that Dr. fellow they hired actually do? He seems more like Regulatory Affairs than a science person.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next